Business | Monday August 20, 2012
The Supreme Court hearing on drug patents pits Swiss drugmaker Novartis AG against India's patent office, which has refused to grant a patent on the company's cancer drug Glivec on the grounds that it is not a new medicine but an amended version of a known compound.
www.ndtv.com/business